ELIZABETH BAUER: Open Payments
NPI 1255721361 · WEISER, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 19 payments from 10 companies in 2025. Trend: 2023 $101 · 2024 $297 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $65 |
| Exact Sciences Corporation | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Amgen Inc. | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| ABBVIE INC. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Viatris Specialty LLC | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| Boston Scientific Corporation | 1 | $14 |
Products named: The Cologuard Plus Collection Kit, CAPLYTA, Rybelsus, LEQVIO, REXULTI, ENTRESTO, Wegovy, EVENITY.
Industry payments across ID — which companies pay providers there.
